Inhibitex (INHX -6.4%) had an interesting day. Shares fell as much as 16% in early trading,...

|By:, SA News Editor

Inhibitex (INHX -6.4%) had an interesting day. Shares fell as much as 16% in early trading, apparently due to cautious comments from BofA's Rachel McMinn, who thinks there could be considerable downside if a safety check for the company's INX-189 hepatitis drug turns up any issues. However, shares pared the majority of their losses after other analysts came to Inhibitex's defense.